EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma.

MLA

Colombino, Maria, et al. “EGFR, KRAS, BRAF, ALK, and CMET Genetic Alterations in 1440 Sardinian Patients with Lung Adenocarcinoma.” BMC Pulmonary Medicine, vol. 19, no. 1, Nov. 2019, p. 209. EBSCOhost, https://doi.org/10.1186/s12890-019-0964-x.

APA

Colombino, M., Paliogiannis, P., Cossu, A., Santeufemia, D. A., Sini, M. C., Casula, M., Palomba, G., Manca, A., Pisano, M., Doneddu, V., & Palmieri, G. (2019). EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma. BMC Pulmonary Medicine, 19(1), 209. https://doi.org/10.1186/s12890-019-0964-x

Chicago

Colombino, Maria, Panagiotis Paliogiannis, Antonio Cossu, Davide Adriano Santeufemia, Maria Cristina Sini, Milena Casula, Grazia Palomba, et al. 2019. “EGFR, KRAS, BRAF, ALK, and CMET Genetic Alterations in 1440 Sardinian Patients with Lung Adenocarcinoma.” BMC Pulmonary Medicine 19 (1): 209. doi:10.1186/s12890-019-0964-x.